Your browser doesn't support javascript.
loading
Escin's Action on Bradykinin Pathway: Advantageous Clinical Properties for an Unknown Mechanism?
Marcianò, Gianmarco; Vocca, Cristina; Diraçoglu, Demirhan; Sevgin, Rotinda Özdas; Gallelli, Luca.
Affiliation
  • Marcianò G; Operative Unit of Pharmacology and Pharmacovigilance, "Renato Dulbecco" University Hospital, 88100 Catanzaro, Italy.
  • Vocca C; Operative Unit of Pharmacology and Pharmacovigilance, "Renato Dulbecco" University Hospital, 88100 Catanzaro, Italy.
  • Diraçoglu D; Department of Physical Medicine and Rehabilitation, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Türkiye.
  • Sevgin RÖ; Department of Physical Medicine and Rehabilitation, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Türkiye.
  • Gallelli L; Operative Unit of Pharmacology and Pharmacovigilance, "Renato Dulbecco" University Hospital, 88100 Catanzaro, Italy.
Antioxidants (Basel) ; 13(9)2024 Sep 19.
Article in En | MEDLINE | ID: mdl-39334789
ABSTRACT
Escin, extracted from horse chestnut (Aesculus hippocastanum) has anti-edema and anti-inflammatory effects. It is used to treat several clinical conditions, including venous insufficiency, pain, inflammation, and edema. Considering escin's pharmacodynamic, the inhibition of the bradykinin pathway represents a particular effect, decreasing the local edema and conferring an advantage in comparison to other compounds. In this narrative review, we described the effects of escin considering its effects on bradykinin pathway.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Antioxidants (Basel) Year: 2024 Document type: Article Affiliation country: Italy Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Antioxidants (Basel) Year: 2024 Document type: Article Affiliation country: Italy Country of publication: Switzerland